272 related articles for article (PubMed ID: 24316349)
1. A mouse model mimicking human first night effect for the evaluation of hypnotics.
Xu Q; Xu XH; Qu WM; Lazarus M; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2014 Jan; 116():129-36. PubMed ID: 24316349
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
3. Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.
Dijk DJ; James LM; Peters S; Walsh JK; Deacon S
J Psychopharmacol; 2010 Nov; 24(11):1613-8. PubMed ID: 19487320
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret.
Hsu N; Jha SK; Coleman T; Frank MG
Behav Brain Res; 2009 Jul; 201(1):233-6. PubMed ID: 19428639
[TBL] [Abstract][Full Text] [Related]
5. GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice.
Xu XH; Qiu MH; Dong H; Qu WM; Urade Y; Huang ZL
Eur Neuropsychopharmacol; 2014 Apr; 24(4):585-94. PubMed ID: 24080505
[TBL] [Abstract][Full Text] [Related]
6. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects.
Struyk A; Gargano C; Drexel M; Stoch SA; Svetnik V; Ma J; Mayleben D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1649-56. PubMed ID: 27554636
[TBL] [Abstract][Full Text] [Related]
8. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype.
Tobler I; Kopp C; Deboer T; Rudolph U
Proc Natl Acad Sci U S A; 2001 May; 98(11):6464-9. PubMed ID: 11353839
[TBL] [Abstract][Full Text] [Related]
9. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
Monti JM; Alvariño F; Monti D
Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
[TBL] [Abstract][Full Text] [Related]
10. Effects of amphetamine, diazepam and caffeine on polysomnography (EEG, EMG, EOG)-derived variables measured using telemetry in Cynomolgus monkeys.
Authier S; Bassett L; Pouliot M; Rachalski A; Troncy E; Paquette D; Mongrain V
J Pharmacol Toxicol Methods; 2014; 70(1):86-93. PubMed ID: 24878255
[TBL] [Abstract][Full Text] [Related]
11. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABA(A) receptor in mice.
Chen CR; Zhou XZ; Luo YJ; Huang ZL; Urade Y; Qu WM
Neuropharmacology; 2012 Nov; 63(6):1191-9. PubMed ID: 22771461
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.
Hambrecht-Wiedbusch VS; Gauthier EA; Baghdoyan HA; Lydic R
Sleep; 2010 Jul; 33(7):909-18. PubMed ID: 20614851
[TBL] [Abstract][Full Text] [Related]
13. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice.
Qu WM; Xu XH; Yan MM; Wang YQ; Urade Y; Huang ZL
J Neurosci; 2010 Mar; 30(12):4382-9. PubMed ID: 20335474
[TBL] [Abstract][Full Text] [Related]
14. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
Feige B; Voderholzer U; Riemann D; Hohagen F; Berger M
Clin Neurophysiol; 1999 Nov; 110(11):1965-74. PubMed ID: 10576495
[TBL] [Abstract][Full Text] [Related]
15. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia.
Lundahl J; Deacon S; Maurice D; Staner L
J Psychopharmacol; 2012 Aug; 26(8):1081-7. PubMed ID: 22057018
[TBL] [Abstract][Full Text] [Related]
16. NREM sleep hypersomnia and reduced sleep/wake continuity in a neuroendocrine mouse model of anxiety/depression based on chronic corticosterone administration.
Le Dantec Y; Hache G; Guilloux JP; Guiard BP; David DJ; Adrien J; Escourrou P
Neuroscience; 2014 Aug; 274():357-68. PubMed ID: 24909899
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
Arbon EL; Knurowska M; Dijk DJ
J Psychopharmacol; 2015 Jul; 29(7):764-76. PubMed ID: 25922426
[TBL] [Abstract][Full Text] [Related]
18. Relevance of the metabotropic glutamate receptor (mGluR5) in the regulation of NREM-REM sleep cycle and homeostasis: evidence from mGluR5 (-/-) mice.
Ahnaou A; Raeymaekers L; Steckler T; Drinkenbrug WH
Behav Brain Res; 2015 Apr; 282():218-26. PubMed ID: 25591476
[TBL] [Abstract][Full Text] [Related]
19. Response of delta (0-3 Hz) EEG and eye movement density to a night with 100 minutes of sleep.
Feinberg I; Baker T; Leder R; March JD
Sleep; 1988 Oct; 11(5):473-87. PubMed ID: 3227227
[TBL] [Abstract][Full Text] [Related]
20. REM and NREM power spectral analysis on two consecutive nights in psychophysiological and paradoxical insomnia sufferers.
St-Jean G; Turcotte I; Pérusse AD; Bastien CH
Int J Psychophysiol; 2013 Aug; 89(2):181-94. PubMed ID: 23770085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
